)
The owner of such brands as Dr LeWinn's and Manicare has seen its share price rise 19 per cent this morning after unaudited June half earnings for McPherson's Group (ASX: MCP) surged 150 per cent on the prior six months.
A shift from its direct-to-store distribution model to third-party wholesaler arrangements via its partner Excel Logistics with the likes of Symbion Pty Ltd, Clifford Hallam Healthcare and a subsidiary of Sigma Healthcare (ASX: SIG), which merged with Chemist Warehouse earlier this year, is expected to generate underlying EBIT benefits of $4-5 million.
McPherson's has forecast a 30 per cent reduction in revenue for FY25 to $139 million, and a more than 50 per cent reduction in underlying EBITDA to $7 million. But on a half-yearly basis, this last figure went from just $2 million in the December half to an expected $5-5.5 million in the June half.
Revenue was mainly brought down by skincare brand Dr LeWinn, while sales were up for its other brands such as Fusion Health (10.4 per cent), Lady Jayne (4.5 per cent), Manicare (3.1 per cent) and Swisspers (1.4 per cent).
Shares rose by as much as 25 per cent in early trading, but at the time of publication before noon are up by almost 19 per cent at 31.5 cents per share (cps).
This lift is despite the company reporting additional non-cash intangible asset impairments of $9-11 million, based on a changed outlook for Dr LeWinn’s in the international business, reflecting sustained competitor intensity in the facial skincare category in China, as well as current trading performance in Australia and New Zealand.
"The FY25 financial year results reflect a year of transitioning from the McPherson’s direct-to-store operating model to a new third-party warehousing and pharmacy wholesaler model which is now in operation," the company reported today.
"The new operating model, combined with earlier progress on strategic initiatives and the Company’s investment in its cost base, has been deliberately established to support the further growth of the business, and positions the company well to realise the benefits of future scale."
Today's double-digit share price jump may be significant but it only returns the share price to levels seen in mid-February before the group revealed a statutory net loss after tax of $900,000 for the December half, flagging anticipated material items of $9-11 million - a range which has materialised at the upper end in today's update.
Prior to announcing its December half results, McPherson's also revealed its CEO and managing director Brett Charlton had been charged with contravening section 1308 of the Corporations Act, relating to false or misleading statements, for alleged conduct in 2018 when he was CEO of Irexchange Limited - a company that went into administration in October 2019.
In March this year, the Australian Securities and Investments Commission (ASIC) revealed Charlton was one of three former executives of the company who had been charged, with the others being former CFO Brett Coventry and former company secretary and legal advisor Anand Sundaraj.
The charges relate to conduct that allegedly occurred between 20 July 2018 and 14 February 2019, concerning an agreement regarding the shares of the founders of IRX and information about the nature of IRX’s business in the prospectus lodged with ASIC.
In ASIC's announcement in March it noted the matter was due to be heard by the Downing Centre Local Court on 29 July, 2025.
)
